Avandia® (rosiglitazone maleate)

SmithKline Beecham Pharmaceuticals

Efficacy Profile

Anthony S. Rebuck, MD

Vice President and Director

Pulmonary and Diabetes Therapeutic Unit

Previous slide

Next slide

Back to first slide

View graphic version